R. Banchereau, S. Hong, B. Cantarel, N. Baldwin, J. Baisch et al., Personalized immunomonitoring uncovers molecular networks that stratify lupus patients, Cell, vol.165, issue.6, pp.1548-50, 2016.

G. Barturen, L. Beretta, R. Cervera, V. R. Van, and M. E. Alarcon-riquelme, Moving towards a molecular taxonomy of autoimmune rheumatic diseases, Nat Rev Rheumatol, vol.14, issue.2, pp.75-93, 2018.

L. Ronnblom, G. V. Alm, and M. L. Eloranta, The type I interferon system in the development of lupus, Semin Immunol, vol.23, issue.2, pp.113-134, 2011.

B. W. Higgs, Z. Liu, B. White, W. Zhu, W. I. White et al., Patients with systemic lupus erythematosus, myositis, rheumatoid arthritis and scleroderma share activation of a common type I interferon pathway, Ann Rheum Dis, vol.70, issue.11, pp.2029-2065, 2011.

Z. Brkic, N. I. Maria, C. G. Van-helden-meeuwsen, J. P. Van-de-merwe, P. L. Van-daele et al., Prevalence of interferon type I signature in CD14 monocytes of patients with Sjogren's syndrome and association with disease activity and BAFF gene expression, Ann Rheum Dis, vol.72, issue.5, pp.728-763, 2013.

J. Manry, G. Laval, P. E. Fornarino, S. Itan, Y. Fumagalli et al., Evolutionary genetic dissection of human interferons, J Exp Med, vol.208, issue.13, pp.2747-59, 2011.

G. I. Rice, D. Toro, D. Y. Jenkinson, E. M. Forte, G. M. Anderson et al., Gain-of-function mutations in IFIH1 cause a spectrum of human disease phenotypes associated with upregulated type I interferon signaling, Nat Genet, vol.46, issue.5, pp.503-512, 2014.

J. Hua, K. Kirou, C. Lee, and M. K. Crow, Functional assay of type I interferon in systemic lupus erythematosus plasma and association with anti-RNA binding protein autoantibodies, Arthritis Rheum, vol.54, issue.6, pp.1906-1922, 2006.

M. P. Rodero, J. Decalf, V. Bondet, D. Hunt, G. I. Rice et al., Detection of interferon alpha protein reveals differential levels and cellular sources in disease, J Exp Med, vol.214, issue.5, pp.1547-55, 2017.
URL : https://hal.archives-ouvertes.fr/pasteur-01534181

A. Mathian, S. Mouries-martin, K. Dorgham, H. Devilliers, L. Barnabei et al., Monitoring disease activity in systemic lupus erythematosus with singlemolecule array digital ELISA quantification of serum interferon-alpha, Arthritis Rheumatol, vol.71, issue.5, pp.756-765, 2019.

G. I. Rice, G. M. Forte, M. Szynkiewicz, D. S. Chase, A. Aeby et al., Assessment of interferon-related biomarkers in Aicardi-Goutieres syndrome associated with mutations in TREX1, RNASEH2A, RNASEH2B, RNASEH2C, SAMHD1, and ADAR: a case-control study, Lancet Neurol, vol.12, issue.12, pp.1159-69, 2013.

S. Meyer, M. Woodward, C. Hertel, P. Vlaicu, Y. Haque et al., AIREdeficient patients harbor unique high-affinity disease-ameliorating autoantibodies, Cell, vol.166, issue.3, pp.582-95, 2016.

I. Rusinova, S. Forster, S. Yu, A. Kannan, M. Masse et al., Interferome v2.0: an updated database of annotated interferon-regulated genes, Nucleic Acids Res, vol.41, pp.1040-1046, 2013.

A. Llibre, V. Bondet, M. P. Rodero, D. Hunt, Y. J. Crow et al., Development and validation of an ultrasensitive single molecule array digital enzyme-linked immunosorbent assay for human interferon-alpha, J Vis Exp, vol.136, 2018.

M. C. Hochberg, Updating the American college of rheumatology revised criteria for the classification of systemic lupus erythematosus, Arthritis Rheum, vol.40, issue.9, p.1725, 1997.

S. V. Skurkovich and E. I. Eremkina, The probable role of interferon in allergy, Ann Allergy, vol.35, issue.6, pp.356-60, 1975.

L. Ronnblom and M. L. Eloranta, The interferon signature in autoimmune diseases, Curr Opin Rheumatol, vol.25, issue.2, pp.248-53, 2013.

G. I. Rice, I. Melki, M. L. Fremond, T. A. Briggs, M. P. Rodero et al., Assessment of type I interferon signaling in pediatric inflammatory disease, J Clin Immunol, vol.37, issue.2, pp.123-155, 2017.
URL : https://hal.archives-ouvertes.fr/hal-01908851

Y. M. El-sherbiny, A. Psarras, M. Yusof, E. Hensor, R. Tooze et al., A novel two-score system for interferon status segregates autoimmune diseases and correlates with clinical features, Sci Rep, vol.8, issue.1, p.5793, 2018.

C. E. Weckerle, B. S. Franek, J. A. Kelly, M. Kumabe, R. A. Mikolaitis et al., Network analysis of associations between serum interferon-alpha activity, autoantibodies, and clinical features in systemic lupus erythematosus, Arthritis Rheum, vol.63, issue.4, pp.1044-53, 2011.

K. A. Kirou, C. Lee, S. George, K. Louca, M. G. Peterson et al., Activation of the interferon-alpha pathway identifies a subgroup of systemic lupus erythematosus patients with distinct serologic features and active disease, Arthritis Rheum, vol.52, issue.5, pp.1491-503, 2005.

T. Rose, A. Grutzkau, H. Hirseland, D. Huscher, C. Dahnrich et al., IFNalpha and its response proteins, IP-10 and SIGLEC-1, are biomarkers of disease activity in systemic lupus erythematosus, Ann Rheum Dis, vol.72, issue.10, pp.1639-1684, 2013.

W. P. Kennedy, R. Maciuca, K. Wolslegel, W. Tew, A. R. Abbas et al., Association of the interferon signature metric with serological disease manifestations but not global activity scores in multiple cohorts of patients with SLE, Lupus Sci Med, vol.2, issue.1, p.80, 2015.

C. Landolt-marticorena, G. Bonventi, A. Lubovich, C. Ferguson, T. Unnithan et al., Lack of association between the interferon-alpha signature and longitudinal changes in disease activity in systemic lupus erythematosus, Ann Rheum Dis, vol.68, issue.9, pp.1440-1446, 2009.

M. Petri, W. Fu, A. Ranger, N. Allaire, P. Cullen et al., Association between changes in gene signatures expression and disease activity among patients with systemic lupus erythematosus, BMC Med Genet, vol.12, issue.1, p.4, 2019.

J. Wither, S. R. Johnson, T. Liu, B. Noamani, D. Bonilla et al., Presence of an interferon signature in individuals who are anti-nuclear antibody positive lacking a systemic autoimmune rheumatic disease diagnosis, Arthritis Res Ther, vol.19, issue.1, p.41, 2017.

M. Yusof, M. Y. Psarras, A. El-sherbiny, Y. M. Hensor, E. Dutton et al., Prediction of autoimmune connective tissue disease in an at-risk cohort: prognostic value of a novel two-score system for interferon status, Ann Rheum Dis, vol.77, pp.1432-1441, 2018.

A. Schattner, A. Meshorer, and D. Wallach, Involvement of interferon in virusinduced lymphopenia, Cell Immunol, vol.79, issue.1, pp.11-25, 1983.

M. Schmid, A. Kreil, W. Jessner, M. Homoncik, C. Datz et al., Suppression of haematopoiesis during therapy of chronic hepatitis C with different interferon alpha mono and combination therapy regimens, Gut, vol.54, issue.7, pp.1014-1034, 2005.

Y. J. Crow and N. Manel, Aicardi-Goutieres syndrome and the type I interferonopathies, Nat Rev Immunol, vol.15, issue.7, pp.429-469, 2015.

T. A. Briggs, G. I. Rice, N. Adib, L. Ades, S. Barete et al., Spondyloenchondrodysplasia due to mutations in ACP5: a comprehensive survey, J Clin Immunol, vol.36, issue.3, pp.220-254, 2016.

T. Koudriavtseva, D. Plantone, R. R. Mandoj, C. Giannarelli, D. Mainero et al., Interferon-beta therapy and risk of thrombocytopenia in multiple sclerosis patients, Neurol Sci, vol.36, issue.12, pp.2263-2271, 2015.

E. Kamphuis, T. Junt, Z. Waibler, R. Forster, and U. Kalinke, Type I interferons directly regulate lymphocyte recirculation and cause transient blood lymphopenia, Blood, vol.108, issue.10, pp.3253-61, 2006.

T. Lovgren, M. L. Eloranta, B. Kastner, M. Wahren-herlenius, G. V. Alm et al., Induction of interferon-alpha by immune complexes or liposomes containing systemic lupus erythematosus autoantigen-and Sjogren's syndrome autoantigen-associated RNA, Arthritis Rheum, vol.54, issue.6, pp.1917-1944, 2006.

R. Lande, D. Ganguly, V. Facchinetti, L. Frasca, C. Conrad et al., Neutrophils activate plasmacytoid dendritic cells by releasing self-DNApeptide complexes in systemic lupus erythematosus, Sci Transl Med, vol.3, issue.73, pp.73-92, 2011.

S. K. Chauhan, V. V. Singh, R. Rai, M. Rai, and G. Rai, Distinct autoantibody profiles in systemic lupus erythematosus patients are selectively associated with TLR7 and TLR9 upregulation, J Clin Immunol, vol.33, issue.5, pp.954-64, 2013.

N. I. Maria, E. C. Steenwijk, A. S. Ijpma, C. G. Van-helden-meeuwsen, P. Vogelsang et al., Contrasting expression pattern of RNA-sensing receptors TLR7, RIG-I and MDA5 in interferon-positive and interferon-negative patients with primary Sjogren's syndrome, Ann Rheum Dis, vol.76, issue.4, pp.721-751, 2017.

M. J. Wahadat, I. Bodewes, N. I. Maria, C. G. Van-helden-meeuwsen, A. Van-dijkhummelman et al., Type I IFN signature in childhood-onset systemic lupus erythematosus: a conspiracy of DNA-and RNA-sensing receptors?, Arthritis Res Ther, vol.20, issue.1, p.4, 2018.

J. E. Downes and S. Marshall-clarke, Innate immune stimuli modulate bone marrowderived dendritic cell production in vitro by toll-like receptor-dependent and -independent mechanisms, Immunology, vol.131, issue.4, pp.513-537, 2010.